Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis A Multinational, Multicenter Study of 362 Patients

Date
2014
Author
Espada, Graciela
Wouters, Carine
Shenoi, Susan
Ozen, Seza
Anton, Jordi
Khubchandani, Raju
Russo, Ricardo
Pal, Priyankar
Miettunen, Paivi
Maritsi, Despoina
Merino, Rosa
Shakoory, Bita
Alessio, Maria
Chasnyk, Vyacheslav
Sanner, Helga
Gao, Yi-Jin
Zeng Huasong, Zeng Huasong
Kitoh, Toshiyuki
Avcin, Tadej
Fischbach, Michel
Frosch, Michael
Grom, Alexei
Huber, Adam
Jelusic, Marija
Sawhney, Sujata
Uziel, Yosef
Ruperto, Nicolino
Martini, Alberto
Cron, Randy Q.
Ravelli, Angelo
Kasapcopur, Ozgur
Minoia, Francesca
Davi, Sergio
Horne, AnnaCarin
Demirkaya, Erkan
Bovis, Francesca
Li, Caifeng
Lehmberg, Kai
Weitzman, Sheila
Insalaco, Antonella
Metadata
Show full item record
Abstract
Objective. To describe the clinical, laboratory, and histopathologic features, current treatment, and outcome of patients with macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (JIA).
URI
http://hdl.handle.net/20.500.12627/143327
https://doi.org/10.1002/art.38802
Collections